Increased fibroblast growth factor 21 is associated with metabolic syndrome in chronic spinal cord injury: A cross-sectional study
In people with chronic SCI, MetS is an independent positive associated factor of plasma FGF21 level, which may suggest the presence of FGF21-resistant condition. This result addresses the interesting role of FGF21 in the development of cardiometabolic diseases in people with chronic SCI.
Authors
- Nattayaporn Apaijai (ORCID: https://orcid.org/0000-0002-1265-5210)
- Sintip Pattanakuhar (ORCID: https://orcid.org/0000-0003-2568-5897)
- Siriporn Chattipakorn
- Nipon Chattipakorn
Institutions
- University of Strathclyde (GB)
- Chiang Mai University (TH)
Publication Details
- Journal
- Journal of Spinal Cord Medicine
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1080/10790268.2025.2609474
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00